|
Real-time Estimate
Cboe BZX
21:40:49 03/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 80.72 USD | +1.63% |
|
-4.67% | -17.73% |
Company Valuation: IRADIMED CORPORATION
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 570.3 | 355.5 | 598.4 | 697 | 1,238 | 1,016 | - | - |
| Change | - | -37.67% | 68.32% | 16.49% | 77.54% | -17.93% | - | - |
| Enterprise Value (EV) | 570.3 | 355.5 | 598.4 | 697 | 1,238 | 1,016 | 1,016 | 1,016 |
| Change | - | -37.67% | 68.32% | 16.49% | 77.54% | -17.93% | 0% | 0% |
| P/E | 62.4x | 27.7x | 35.2x | 36.7x | 55.6x | 41.4x | 35.2x | 32.4x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.7x | 1.1x | 3.3x | 3.3x | 4.35x | 2x | 3.71x |
| Capitalization / Revenue | 13.6x | 6.67x | 9.13x | 9.52x | 14.8x | 11x | 9.93x | 9.15x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 11x | 9.93x | 9.15x |
| EV / EBITDA | - | - | - | - | - | 29.4x | 27.4x | 24.2x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 33.4x | 29.3x | 26.8x |
| EV / FCF | - | - | - | - | - | 41.3x | 36.8x | 31.2x |
| FCF Yield | - | - | - | - | - | 2.42% | 2.72% | 3.21% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.74 | 1.02 | 1.35 | 1.5 | 1.75 | 1.917 | 2.253 | 2.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 41.81 | 53.3 | 65.56 | 73.24 | 83.81 | 92.05 | 102.3 | 111 |
| EBITDA 1 | - | - | - | - | - | 34.5 | 37.1 | 42 |
| EBIT 1 | 9.818 | 15.63 | 20.04 | 21.96 | 26.15 | 30.4 | 34.63 | 37.85 |
| Net income 1 | 9.325 | 12.83 | 17.19 | 19.23 | 22.48 | 24.63 | 28.45 | 31.65 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 46.21 | 28.29 | 47.47 | 55.00 | 97.28 | 79.42 | 79.42 | 79.42 |
| Nbr of stocks (in thousands) | 12,342 | 12,566 | 12,606 | 12,673 | 12,721 | 12,788 | - | - |
| Announcement Date | 04/02/22 | 02/02/23 | 08/02/24 | 13/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 41.44x | - | - | - | 1.02B | ||
| 34.96x | 5.97x | 22.82x | 0.27% | 253B | ||
| 36.24x | 6.89x | 21.57x | 0.64% | 160B | ||
| 50.32x | 12.19x | 26.16x | -.--% | 151B | ||
| 18.13x | 3.61x | 11.78x | -.--% | 64.23B | ||
| 21.25x | 2.53x | 12.78x | 2.38% | 54.11B | ||
| 36.97x | 7.41x | 23.45x | -.--% | 53.76B | ||
| 47x | 11.56x | 25.47x | -.--% | 49.71B | ||
| 33.51x | 6.64x | 22.56x | 0.6% | 48.49B | ||
| 78.69x | 7.5x | 22.76x | -.--% | 44.17B | ||
| Average | 39.85x | 7.15x | 21.04x | 0.43% | 88.02B | |
| Weighted average by Cap. | 38.69x | 7.34x | 21.92x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IRMD Stock
- Valuation IRADIMED CORPORATION
Select your edition
All financial news and data tailored to specific country editions
















